Could a single injection repair arthritic knees?
Disease control
Completed
This Phase 3 trial tested a single injection of TG-C, a cell-based treatment, in 531 people with moderate knee osteoarthritis. The goal was to see if it reduces pain and improves knee function compared to a placebo injection. Participants were followed for 24 months to check safe…
Phase: PHASE3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC